|
Mechanismσ1 receptor agonists |
|
|
|
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
ST-605 uncontrolled open-label phase 2 study in patients with herpes simplex virus keratitis
ST-605 phase 2 study - uncontrolled open-label study in patients with cytomegalovirus corneal endotheliitis -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Phase IIa Study of Safety and Motor Function Restoration in Subjects Treated With SA4503 Following Acute Ischemic Stroke
The purpose of this study is to evaluate the safety and tolerability of SA4503 in patients recovering from a recent stroke. Secondary, to evaluate the efficacy of SA4503 compared to placebo.
100 Clinical Results associated with M's Science Corp.
0 Patents (Medical) associated with M's Science Corp.
100 Deals associated with M's Science Corp.
100 Translational Medicine associated with M's Science Corp.